Deutsche Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.98M Sell
52,244
-526
-1% -$80.6K ﹤0.01% 1127
2025
Q4
$7.28M Sell
52,770
-198
-0.4% -$25.9K ﹤0.01% 1176
2025
Q3
$6.79M Buy
52,968
+2,301
+5% +$281K ﹤0.01% 1185
2025
Q2
$6.13M Sell
50,667
-375
-0.7% -$42.3K ﹤0.01% 1159
2025
Q1
$5.69M Buy
51,042
+2,500
+5% +$266K ﹤0.01% 1203
2024
Q4
$4.72M Hold
48,542
﹤0.01% 1357
2024
Q3
$5.58M Hold
48,542
﹤0.01% 1239
2024
Q2
$5.17M Hold
48,542
﹤0.01% 1236
2024
Q1
$4.7M Sell
48,542
-110
-0.2% -$11.3K ﹤0.01% 1292
2023
Q4
$4.91M Sell
48,652
-1,587
-3% -$153K ﹤0.01% 1263
2023
Q3
$5.12M Sell
50,239
-761
-1% -$77.2K ﹤0.01% 1026
2023
Q2
$5.15M Buy
51,000
+45,066
+759% +$4.51M ﹤0.01% 1225
2023
Q1
$546K Sell
5,934
-36
-0.6% -$3.14K ﹤0.01% 2446
2022
Q4
$542K Sell
5,970
-42
-0.7% -$3.54K ﹤0.01% 2407
2022
Q3
$457K Buy
6,012
+15
+0.3% +$1.24K ﹤0.01% 2421
2022
Q2
$507K Hold
5,997
﹤0.01% 2592
2022
Q1
$526K Sell
5,997
-9,256
-61% -$801K ﹤0.01% 2715
2021
Q4
$1.33M Sell
15,253
-1,126
-7% -$93.5K ﹤0.01% 2257
2021
Q3
$1.34M Sell
16,379
-496
-3% -$44.6K ﹤0.01% 2423
2021
Q2
$1.54M Sell
16,875
-52,026
-76% -$4.63M ﹤0.01% 2460
2021
Q1
$5.89M Sell
68,901
-28,964
-30% -$2.6M ﹤0.01% 1460
2020
Q4
$9.24M Buy
97,865
+10,072
+11% +$880K 0.01% 1074
2020
Q3
$7.63M Buy
87,793
+4,928
+6% +$427K 0.01% 1071
2020
Q2
$7.24M Buy
82,865
+6,383
+8% +$551K 0.01% 1116
2020
Q1
$6.31M Sell
76,482
-2,083
-3% -$186K 0.01% 1123
2019
Q4
$7.44M Buy
78,565
+8,515
+12% +$764K ﹤0.01% 1229
2019
Q3
$6.08M Buy
70,050
+5,196
+8% +$467K ﹤0.01% 1282
2019
Q2
$5.92M Buy
64,854
+9,807
+18% +$830K ﹤0.01% 1699
2019
Q1
$4.74M Sell
55,047
-562,295
-91% -$45.1M ﹤0.01% 1899
2018
Q4
$47.5M Buy
617,342
+335,010
+119% +$26.1M 0.03% 522
2018
Q3
$21.8M Sell
282,332
-433,251
-61% -$32M 0.01% 1081
2018
Q2
$48.4M Buy
715,583
+648,843
+972% +$44.8M 0.02% 688
2018
Q1
$4.83M Buy
66,740
+42,662
+177% +$3.25M ﹤0.01% 2241
2017
Q4
$1.81M Sell
24,078
-15,231
-39% -$1.15M ﹤0.01% 2789
2017
Q3
$3.02M Buy
39,309
+994
+3% +$75.1K ﹤0.01% 2249
2017
Q2
$2.86M Sell
38,315
-345,628
-90% -$24.5M ﹤0.01% 2325
2017
Q1
$25.5M Buy
383,943
+356,180
+1,283% +$23.7M 0.02% 772
2016
Q4
$1.81M Sell
27,763
-108,563
-80% -$7.04M ﹤0.01% 2325
2016
Q3
$9.64M Sell
136,326
-12,822
-9% -$934K 0.01% 1333
2016
Q2
$11M Sell
149,148
-173,671
-54% -$12M 0.01% 1247
2016
Q1
$21M Sell
322,819
-160,681
-33% -$10.9M 0.02% 872
2015
Q4
$37.3M Buy
483,500
+204,600
+73% +$16.3M 0.03% 649
2015
Q3
$23M Buy
278,900
+66,699
+31% +$5.94M 0.02% 823
2015
Q2
$18.7M Sell
212,201
-30,138
-12% -$2.76M 0.01% 966
2015
Q1
$21.4M Buy
242,339
+80,247
+50% +$7.12M 0.01% 898
2014
Q4
$13.5M Sell
162,092
-3,622
-2% -$300K 0.01% 1239
2014
Q3
$14M Sell
165,714
-5,363
-3% -$434K 0.01% 1161
2014
Q2
$13.9M Buy
171,077
+100,671
+143% +$7.92M 0.01% 1158
2014
Q1
$5.36M Sell
70,406
-44,483
-39% -$3.24M ﹤0.01% 1771
2013
Q4
$8.27M Sell
114,889
-23,513
-17% -$1.63M 0.01% 1445
2013
Q3
$9.51M Buy
138,402
+65,461
+90% +$4.33M 0.01% 1362
2013
Q2
$4.62M Buy
+72,941
New +$4.75M ﹤0.01% 1663

Other funds holding NVS

Deutsche Bank's NVS Position: Q1 2026 in Review

Deutsche Bank reduced its Novartis (NVS) stake by 1% in Q1 2026, selling an estimated $80.6K and leaving 52,244 shares worth $7.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Deutsche Bank first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.4M in Q2 2018. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Deutsche Bank held 52,244 shares of Novartis worth $7.98M as of Q1 2026.
  • Deutsche Bank sold 526 Novartis shares in Q1 2026, an estimated $80.6K.
  • Novartis made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1127 holding.
  • Deutsche Bank first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Novartis position peaked at $48.4M in Q2 2018.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.